org placeholder image

Joshua Pirkle

Research Associate II at CRISPR Therapeutics

  • LinkedIn

Email Email: j****@crisprtx.com

phone noPhone Number: (***)-***-****

map
CRISPR THERAPEUTICS

CRISPR THERAPEUTICS

  • description Description
    CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

CRISPR Therapeutics Org Chart and Mapping

Employees

Aditi Sakhi

Senior Research Associate

Eric Blahut

Director of Internal Manufacturing

Harshi Gangrade

Research Associate II, Regenerative Medicine

Kamilla Fellah

Research Operations Manager

Paul Stevens

Executive Director and Head of Msat

John Norsworthy

Senior Facilities Process Specialist

Sushant Karnik

Principal Research Associate

Frequently Asked Questions Regarding Joshua Pirkle

Answer: Joshua Pirkle works for CRISPR Therapeutics as Research Associate II

Answer: Joshua Pirkle’s role in CRISPR Therapeutics is Research Associate II

Answer: Joshua Pirkle's email address is j***@gmail.com

Answer: Joshua Pirkle's business email address is j****@crisprtx.com

Answer: Joshua Pirkle’s direct phone number is (***)-***-****

Answer: Joshua Pirkle works in the industry of: Biotechnology

Answer: Joshua Pirkle works CRISPR Therapeutics located at 828 Winter St, Boston, Massachusetts, 02451, United States

Answer: CRISPR Therapeutics's Research Associate II is Joshua Pirkle

Answer: Joshua Pirkle contact details:

  • Phone number  :  (***)-***-****
  • Email  :  j****@crisprtx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access